Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Oncotarget
|
July 21, 2016
Prognostic impact of MYH9 expression on patients with acute myeloid leukemia
Mengxia Yu, Jinghan Wang, Zhijuan Zhu, et al.
British Journal of Haematology
|
November 8, 2023
Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemia
Nianci Chen, Jiajia Pan, Yile Zhou, et al.
Journal of Hematology & Oncology
|
November 12, 2025
MicroRNA-142 improves IL1RAP CAR-T cell activity in acute myeloid leukemia
Kaito Harada, Dandan Zhao, Miso Park, et al.
Haematologica
|
September 2, 2017
HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis
Rui Huang, Yoshihiro Hayashi, Xiaomei Yan, et al.
Leukemia
|
April 11, 2019
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints
Yunzhu Dong, Xinghui Zhao, Xiaomin Feng, et al.
Haematologica
|
September 29, 2018
The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes
Peipei Lin, Yanling Ren, Xiaomei Yan, et al.
Haematologica
|
April 13, 2019
Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC
Chenying Li, Lei Dong, Rui Su, et al.
BMC Infectious Diseases
|
October 11, 2024
Inactivated vaccine dosage and serum IgG levels correlate with persistent COVID-19 infections in hematologic malignancy patients during the Omicron Surge in China
Li Ye, Ye Yang, Xuewu Zhang, et al.
American Journal of Hematology
|
May 26, 2026
Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA Group
Jiajia Pan, Chunmei Fu, Qing Ling, et al.
Cancer Discovery
|
August 25, 2018
Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic Syndromes
Yoshihiro Hayashi, Yue Zhang, Asumi Yokota, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Oncotarget
|
July 21, 2016
Prognostic impact of MYH9 expression on patients with acute myeloid leukemia
Mengxia Yu, Jinghan Wang, Zhijuan Zhu, et al.
British Journal of Haematology
|
November 8, 2023
Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemia
Nianci Chen, Jiajia Pan, Yile Zhou, et al.
Journal of Hematology & Oncology
|
November 12, 2025
MicroRNA-142 improves IL1RAP CAR-T cell activity in acute myeloid leukemia
Kaito Harada, Dandan Zhao, Miso Park, et al.
Haematologica
|
September 2, 2017
HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis
Rui Huang, Yoshihiro Hayashi, Xiaomei Yan, et al.
Leukemia
|
April 11, 2019
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints
Yunzhu Dong, Xinghui Zhao, Xiaomin Feng, et al.
Haematologica
|
September 29, 2018
The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes
Peipei Lin, Yanling Ren, Xiaomei Yan, et al.
Haematologica
|
April 13, 2019
Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC
Chenying Li, Lei Dong, Rui Su, et al.
BMC Infectious Diseases
|
October 11, 2024
Inactivated vaccine dosage and serum IgG levels correlate with persistent COVID-19 infections in hematologic malignancy patients during the Omicron Surge in China
Li Ye, Ye Yang, Xuewu Zhang, et al.
American Journal of Hematology
|
May 26, 2026
Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA Group
Jiajia Pan, Chunmei Fu, Qing Ling, et al.
Cancer Discovery
|
August 25, 2018
Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic Syndromes
Yoshihiro Hayashi, Yue Zhang, Asumi Yokota, et al.
Page
of 5